Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Response in Individuals With Prediabetes
- Sponsor
- Diabetes Foundation, India
- Study ID
- NCT07762768
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Prediabetes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 60 Years
- Healthy Volunteers
- Not accepted
Interventions
- Intervention Group — DIETARY_SUPPLEMENTHigh-Protein, Low-Glycaemic Index Rice
Study Details
This is a randomized, controlled, two-phase crossover study will be conducted in adults aged 18-60 years with prediabetes to compare the effects of a CSIR-developed high-protein, low-glycaemic index rice with conventional rice. Phase I will evaluate acute postprandial glucose, insulin, C-peptide, GLP-1, and hunger/satiety responses, while Phase II will assess 72-hour continuous glucose monitoring (CGM) outcomes, including mean glucose and glycaemic variability. Eligible participants will be randomly assigned to receive both rice types in a crossover manner, with each participant serving as their own control. Individuals with diabetes, major systemic illnesses, abnormal liver or renal function, pregnancy, or glucose-lowering medication use will be excluded.
Key Dates
- First listed
- Aug 13, 2026
- Start date
- Sep 1, 2026
- Status verified
- Aug 2026
- Primary completion
- Feb 15, 2027
- Completion
- Feb 28, 2027
Study Design
- Enrollment
- 36 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- PREVENTION
Arms
- Active Comparator: Intervention GroupCSIR-Developed High-Protein, Low-Glycaemic Index Rice
- Active Comparator: Control GroupConventional Rice
Primary Outcome Measure
Study Phase 1: Meal Tolerance Test [ Time Frame: 1 day ]
Central Contacts
- Anoop Misra, M.D.011-41759672
- Seema Gulati, Ph.d011-41759672
Related Studies
- Blood Markers of Early Pancreas CancerRecruiting · University of Nebraska · Omaha, Nebraska
- Bromocriptine for Patients With Schizophrenia and PrediabetesPHASE4 · Not Yet Recruiting · VA Pittsburgh Healthcare System · Pittsburgh, Pennsylvania
- Glucose Variability and Cognition in PrediabetesRecruiting · University of Maryland, Baltimore · Baltimore, Maryland
- Mechanisms for Activation of Beige Adipose Tissue in HumansPHASE2 · Recruiting · Philip Kern · Lexington, Kentucky